A single infection with Chlamydia pneumoniae is sufficient to exacerbate atherosclerosis in ApoE deficient mice

Cellular Immunology

Volumn 294, Issue 1, 2015, Pages 25-32

  Sorrentino, Rosalinda ^a,b   Yilmaz, Atilla ^c   Schubert, Katja ^c   Crother, Timothy R ^a   Pinto, Aldo ^b   Shimada, Kenichi ^a   Arditi, Moshe ^a   Chen, Shuang ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SALERNO   (Italy)

^c JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Atherosclerosis; C. pneumoniae; Innate immunity

Indexed keywords

CHOLESTEROL; GAMMA INTERFERON; INTERLEUKIN 10; TRIACYLGLYCEROL; APOLIPOPROTEIN E; LIPID;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA SINUS; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHLAMYDIAL PNEUMONIA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE EXACERBATION; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; LIPID DIET; MOUSE; MYELOID DENDRITIC CELL; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; T LYMPHOCYTE; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BIOSYNTHESIS; BLOOD; C57BL MOUSE; CHLAMYDIA PNEUMONIAE; CHLAMYDOPHILA INFECTION; DENDRITIC CELL; DISEASE COURSE; GENETICS; IMMUNOLOGY; MICROBIOLOGY; PATHOLOGY; TH1 CELL;

CHLAMYDOPHILA PNEUMONIAE; MUS;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DENDRITIC CELLS; DISEASE PROGRESSION; INTERFERON-GAMMA; LIPIDS; MICE; MICE, INBRED C57BL; PLAQUE, ATHEROSCLEROTIC; SINUS OF VALSALVA; TH1 CELLS;

EID: 84922980215     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2015.01.007     Document Type: Article

References (35)

1. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 2005, 352:1685-1695.
2. Sorrentino R., Arditi M. Innate immunity, Toll-like receptors, and atherosclerosis: mouse models and methods. Methods Mol. Biol. 2009, 517:381-399.
3. Saikku P., Leinonen M., Mattila K., Ekman M.R., Nieminen M.S., Makela P.H., Huttunen J.K., Valtonen V. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988, 2:983-986.
4. Kuo C.C., Gown A.M., Benditt E.P., Grayston J.T. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler. Thromb. 1993, 13:1501-1504.
5. Blessing E., Campbell L.A., Rosenfeld M.E., Chough N., Kuo C.C. Chlamydia pneumoniae infection accelerates hyperlipidemia induced atherosclerotic lesion development in C57BL/6J mice. Atherosclerosis 2001, 158:13-17.
6. Moazed T.C., Campbell L.A., Rosenfeld M.E., Grayston J.T., Kuo C.C. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. J. Infect. Dis. 1999, 180:238-241.
7. Tormakangas L., Erkkila L., Korhonen T., Tiirola T., Bloigu A., Saikku P., Leinonen M. Effects of repeated Chlamydia pneumoniae inoculations on aortic lipid accumulation and inflammatory response in C57BL/6J mice. Infect. Immun. 2005, 73:6458-6466.
8. Kuo C.C., Shor A., Campbell L.A., Fukushi H., Patton D.L., Grayston J.T. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J. Infect. Dis. 1993, 167:841-849.
9. Grayston J.T., Kuo C.C., Coulson A.S., Campbell L.A., Lawrence R.D., Lee M.J., Strandness E.D., Wang S.P. Chlamydia pneumoniae (Twar) in Atherosclerosis of the Carotid-Artery. Circulation 1995, 92:3397-3400.
10. Kuo C.C., Coulson A.S., Campbell L.A., Cappuccio A.L., Lawrence R.D., Wang S.P., Grayston J.T. Detection of Chlamydia pneumoniae in atherosclerotic plaques in the walls of arteries of lower extremities from patients undergoing bypass operation for arterial obstruction. J. Vasc. Surg. 1997, 26:29-31.
11. Naiki Y., Sorrentino R., Wong M.H., Michelsen K.S., Shimada K., Chen S., Yilmaz A., Slepenkin A., Schroder N.W., Crother T.R., Bulut Y., Doherty T.M., Bradley M., Shaposhnik Z., Peterson E.M., Tontonoz P., Shah P.K., Arditi M. TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis. J. Immunol. 2008, 181:7176-7185.
12. Blessing E., Nagano S., Campbell L.A., Rosenfeld M.E., Kuo C.C. Effect of Chlamydia trachomatis infection on atherosclerosis in apolipoprotein E-deficient mice. Infect. Immun. 2000, 68:7195-7197.
13. Yilmaz A., Arditi M. Giant cell arteritis dendritic cells take two T's to tango. Circ. Res. 2009, 104:425-427.
14. Joshi R., Khandelwal B., Joshi D., Gupta O.P. Chlamydophila pneumoniae infection and cardiovascular disease. N. Am. J. Med. Sci. 2013, 5:169-181.
15. Campbell L.A., Rosenfeld M.E. Persistent C. pneumoniae infection in atherosclerotic lesions: rethinking the clinical trials. Front. Cell. Infect. Microbiol. 2014, 4:34.
16. Michelsen K.S., Wong M.H., Shah P.K., Zhang W., Yano J., Doherty T.M., Akira S., Rajavashisth T.B., Arditi M. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:10679-10684.
17. Yilmaz A., Rowley A., Schulte D.J., Doherty T.M., Schröder N.W., Fishbein M.C., Kalelkar M., Cicha I., Schubert K., Daniel W.G., Garlichs C.D., Arditi M. Activated myeloid dendritic cells accumulate and co-localize with CD3+ T cells in coronary artery lesions in patients with Kawasaki disease. Exp. Mol. Pathol. 2007, 83:93-103.
18. Breel M., Mebius R.E., Kraal G. Dendritic cells of the mouse recognized by 2 monoclonal-antibodies. Eur. J. Immunol. 1987, 17:1555-1559.
19. Inaba K., Pack M., Inaba M., Sakuta H., Isdell F., Steinman R.M. High levels of a major histocompatibility complex II self peptide complex on dendritic cells from the T cell areas of lymph nodes. J. Exp. Med. 1997, 186:665-672.
20. Serafini B., Columba-Cabezas S., Di Rosa F., Aloisi F. Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. Am. J. Pathol. 2000, 157:1991-2002.
21. Bobryshev Y.V., Taksir T., Lord R.S.A., Freeman M.W. Evidence that dendritic cells infiltrate atherosclerotic lesions in apolipoprotein E-deficient mice. Histol. Histopathol. 2001, 16:801-808.
22. Chen S., Shimada K., Zhang W., Huang G., Crother T.R., Arditi M. IL-17A is proatherogenic in high-fat diet-induced and Chlamydia pneumoniae infection-accelerated atherosclerosis in mice. J. Immunol. 2010, 185:5619-5627.
23. Elkind M.S. Infectious burden: a new risk factor and treatment target for atherosclerosis. Infect. Disord. Drug Targets 2010, 10:84-90.
24. Wen H., Ting J.P., O'Neill L.A. A role for the NLRP3 inflammasome in metabolic diseases - did Warburg miss inflammation?. Nat. Immunol. 2012, 13:352-357.
25. Doherty T.M., Fisher E.A., Arditi M. TLR signaling and trapped vascular dendritic cells in the development of atherosclerosis. Trends Immunol. 2006, 27:222-227.
26. Shaposhnik Z., Wang X., Weinstein M., Bennett B.J., Lusis A.J. Granulocyte macrophage colony-stimulating factor regulates dendritic cell content of atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 2007, 27:621-627.
27. Sorrentino R., Morello S., Pinto A. Plasmacytoid dendritic cells: from heart to vessels. Int. J. Vasc. Med. 2010, 2010:430318.
28. Niessner A., Weyand C.M. Dendritic cells in atherosclerotic disease. Clin. Immunol. 2010, 134:25-32.
29. Macritchie N., Grassia G., Sabir S.R., Maddaluno M., Welsh P., Sattar N., Ialenti A., Kurowska-Stolarska M., McInnes I.B., Brewer J.M., Garside P., Maffia P. Plasmacytoid dendritic cells play a key role in promoting atherosclerosis in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2012, 32:2569-2579.
30. Choi J.H., Cheong C., Dandamudi D.B., Park C.G., Rodriguez A., Mehandru S., Velinzon K., Jung I.H., Yoo J.Y., Oh G.T., Steinman R.M. Flt3 signaling-dependent dendritic cells protect against atherosclerosis. Immunity 2011, 35:819-831.
31. Crother T.R., Ma J., Jupelli M., Chiba N., Chen S., Slepenkin A., Alsabeh R., Peterson E., Shimada K., Arditi M. Plasmacytoid dendritic cells play a role for effective innate immune responses during Chlamydia pneumoniae infection in mice. PLoS ONE 2012, 7:e48655.
32. Pinto A., Rega A., Crother T.R., Sorrentino R. Plasmacytoid dendritic cells and their therapeutic activity in cancer. Oncoimmunology 2012, 1:726-734.
33. Sharma M.D., Hou D.Y., Liu Y., Koni P.A., Metz R., Chandler P., Mellor A.L., He Y., Munn D.H. Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes. Blood 2009, 113:6102-6111.
34. Martin-Gayo E., Sierra-Filardi E., Corbi A.L., Toribio M.L. Plasmacytoid dendritic cells resident in human thymus drive natural Treg cell development. Blood 2010, 115:5366-5375.
35. Blasius A.L., Giurisato E., Cella M., Schreiber R.D., Shaw A.S., Colonna M. Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J. Immunol. 2006, 177:3260-3265.